Karyopharm Therapeutics Inc. (44) | Intellectual Property (2)

Browse by Subcategory

License Agreements (2)

Recent Contracts

License Agreement, dated as of December 17, 2021, between the Registrant and Berlin-Chemie AG (Menarini Group) (Filed With SEC on March 1, 2022)
Amendment to License Agreement, dated May 1, 2020, by and between Antengene Therapeutics Limited and the Registrant (Filed With SEC on August 4, 2020)